In this study we systematically evaluate transcript events in subsets of CD4+ T cells to determine whether lymphoid transcriptional dysregulation, in the form of alternative splicing, contributes towards T1D pathology. This evidence concerns the gene CD4 and type 1 diabetes mellitus.